Targovax logoTargovax logo

  • About
    About
      • About Targovax
      • Management Team
      • Board of Directors
      • Careers
      • Research Technician
  • Technology
    Technology
      • ONCOS – Oncolyctic Virus
      • Intellectual Property Rights
      • Publications
  • Pipeline
    Pipeline
      • Our pipeline
      • Development Program
        • Melanoma
        • Mesothelioma
        • Collaboration Trials
        • New viruses
  • Partnering
  • Investors & Media
    Investors & Media
      • Our strategy
      • Press releases
      • Capital markets day 2021
      • Financial Reports
      • Presentations
      • Prospectus
      • Debt
      • Share information
        • Share facts
        • Largest shareholders
        • Dividend policy
        • Analyst coverage
        • Registrar and auditor
      • Events
      • Contact
      • Subscribe
  • Governance
    Governance
      • Corporate Governance Policy
      • Corporate Social Responsibility Principles
      • Remuneration Principles
      • About General Meeting
        • General Meetings
      • Board of Directors
        • Nomination Committee
        • Committees
      • Management
      • Articles of Association
  • Contacts
    Contacts
      • Offices
      • Investors & Media
    • About
      • About Targovax
      • Management Team
      • Board of Directors
      • Collaborations
      • Careers
    • Technology
      • ONCOS – Oncolyctic Virus
      • Intellectual Property Rights
      • Publications
    • Pipeline
      • Our pipeline
      • Development program
    • Partnering
      • TG Mutant RAS neoantigen vaccine – Available for partnering
    • Investors & Media
      • Our strategy
      • Share information
        • Share facts
        • Largest shareholders
        • Dividend policy
        • Analyst coverage
        • Registrar and auditor
      • Financial Reports
      • Press releases
      • Presentations
      • Prospectus
      • Debt
      • Events
      • Subscribe
      • Contact
    • Governance
      • Corporate Governance Report
      • Corporate Social Responsibility Principles
      • About General Meeting
        • General Meetings
      • Board of Directors
        • Nomination Committee
        • Committees
      • Management
      • Articles of Association
    • Contacts
      • Offices
      • Career
      • Investors & Media

    Annual General Meeting 2019

    April 30, 2019

    The Annual General Meeting of Targovax ASA (the “Company”) will be held at the Company’s offices at Lysaker, on 30 April 2019 at 13:00 CET.

    Documents

    • Notice of Annual General Meeting
      English April 9, 2019
    • Recommendations by the nomination committee
      English April 2, 2019
    • Minutes from Annual General Meeting
      English 30 April, 2019
    IR contact
    Dr Lubor Gaal
    Dr Lubor Gaal
    Chief Financial Officer
    lubor.gaal@targovax.com
    (+34) 683 343 811
    Renate Birkeli
    Renate Birkeli
    Investor Relations
    renate.birkeli@targovax.com
    +47 922 61 624

    Annual Report 2021

    Published March 9, 2022.

    • Annual Report 2021
    Archive financial reports

    Share

    • PRINT
    • STAY CONNECTED
    • Terms of use
    • Privacy policy

    This website uses cookies to ensure you get the best experience on our website. Learn More | Terms of Use

    Yes, I accept